Solid Biosciences Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Solid Biosciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Solid Biosciences Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$35.2M, a 52.2% decline year-over-year.
  • Solid Biosciences Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$112M, a 3.82% increase year-over-year.
  • Solid Biosciences Inc. annual Operating Income (Loss) for 2023 was -$104M, a 2.07% increase from 2022.
  • Solid Biosciences Inc. annual Operating Income (Loss) for 2022 was -$106M, a 47.3% decline from 2021.
  • Solid Biosciences Inc. annual Operating Income (Loss) for 2021 was -$72.3M, a 18.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$104M +$2.2M +2.07% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$106M -$34.2M -47.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$72.3M +$16.2M +18.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 -$88.4M +$30.9M +25.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$119M -$43.6M -57.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 -$75.7M -$20.8M -38% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$54.9M -$29.3M -114% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$25.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.